EHealth Income Statement Research

EHTH Stock

USD 4.61 0.27 6.22%

Most accounts from EHealth's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into eHealth current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out EHealth Valuation and EHealth Correlation analysis.

For more detail on how to invest in EHealth Stock please use our How to Invest in EHealth guide.

As of now, EHealth's Other Operating Expenses is increasing as compared to previous years. The EHealth's current Total Operating Expenses is estimated to increase to about 483.3 M, while Depreciation And Amortization is projected to decrease to under 10.3 M.

For more detail on how to invest in EHealth Stock please use our How to Invest in EHealth guide.As of now, EHealth's Other Operating Expenses is increasing as compared to previous years. The EHealth's current Total Operating Expenses is estimated to increase to about 483.3 M, while Depreciation And Amortization is projected to decrease to under 10.3 M.

	2021	2022	2023	2024 (projected)
Gross Profit	536.2M	403.7M	431.2M	218.0M
Total Revenue	538.2M	405.4M	452.9M	475.5M

Gross Profit Total Revenue

EHealth income statement Correlations

	Depreciation And Amortization	Interest Expense	Selling General Administrative	Selling And Marketing Expenses	Total Revenue	Gross Profit	Other Operating Expenses	Operating Income	Ebit	Ebitda	Total Operating Expenses	Income Before Tax	Total Other Income Expense Net	Net Income	Cost Of Revenue	Research Development	Income Tax Expense	Net Income From Continuing Ops	Non Operating Income Net Other	Non Recurring	Tax Provision	Reconciled Depreciation	Extraordinary Items	Net Interest Income
Depreciation And Amortization		0.26	0.72	0.8	0.6	0.65	0.74	-0.54	-0.55	-0.22	0.75	-0.76	-0.71	-0.76	-0.1	0.85	-0.5	-0.73	-0.2	0.59	-0.72	0.77	0.0	-0.23
Interest Expense	0.26		0.35	0.42	0.48	0.47	0.44	0.19	0.17	0.31	0.45	-0.02	-0.58	-0.04	0.0	0.43	0.05	-0.04	-0.25	0.45	0.08	0.48	-0.09	-0.39
Selling General Administrative	0.72	0.35		0.83	0.8	0.84	0.82	-0.11	-0.13	0.16	0.82	-0.3	-0.55	-0.3	0.16	0.8	-0.19	-0.37	-0.18	0.73	-0.24	0.78	-0.14	-0.35
Selling And Marketing Expenses	0.8	0.42	0.83		0.95	0.89	0.99	-0.19	-0.22	0.1	0.99	-0.4	-0.6	-0.4	0.19	0.91	-0.22	-0.47	-0.28	0.81	-0.28	0.88	-0.33	-0.46
Total Revenue	0.6	0.48	0.8	0.95		0.93	0.97	0.09	0.07	0.35	0.97	-0.11	-0.56	-0.12	0.23	0.82	-0.04	-0.22	-0.17	0.86	0.02	0.78	-0.37	-0.44
Gross Profit	0.65	0.47	0.84	0.89	0.93		0.88	0.14	0.13	0.43	0.89	-0.08	-0.64	-0.08	-0.04	0.88	-0.04	-0.13	0.01	0.91	-0.01	0.71	-0.03	-0.21
Other Operating Expenses	0.74	0.44	0.82	0.99	0.97	0.88		-0.16	-0.19	0.12	1.0	-0.35	-0.55	-0.35	0.27	0.89	-0.21	-0.46	-0.33	0.79	-0.21	0.89	-0.42	-0.54
Operating Income	-0.54	0.19	-0.11	-0.19	0.09	0.14	-0.16		0.99	0.93	-0.16	0.94	-0.05	0.91	-0.15	-0.29	0.67	0.91	0.63	0.27	0.91	-0.45	0.19	0.4
Ebit	-0.55	0.17	-0.13	-0.22	0.07	0.13	-0.19	0.99		0.93	-0.18	0.94	-0.06	0.91	-0.18	-0.31	0.68	0.91	0.65	0.23	0.91	-0.47	0.21	0.42
Ebitda	-0.22	0.31	0.16	0.1	0.35	0.43	0.12	0.93	0.93		0.12	0.77	-0.37	0.74	-0.22	0.0	0.58	0.75	0.66	0.53	0.77	-0.21	0.2	0.37
Total Operating Expenses	0.75	0.45	0.82	0.99	0.97	0.89	1.0	-0.16	-0.18	0.12		-0.36	-0.57	-0.36	0.24	0.9	-0.22	-0.45	-0.31	0.8	-0.22	0.88	-0.39	-0.51
Income Before Tax	-0.76	-0.02	-0.3	-0.4	-0.11	-0.08	-0.35	0.94	0.94	0.77	-0.36		0.28	0.98	-0.06	-0.49	0.69	0.95	0.53	0.01	0.95	-0.59	0.14	0.38
Total Other Income Expense Net	-0.71	-0.58	-0.55	-0.6	-0.56	-0.64	-0.55	-0.05	-0.06	-0.37	-0.57	0.28		0.29	0.31	-0.6	0.13	0.22	-0.25	-0.7	0.22	-0.44	-0.17	-0.06
Net Income	-0.76	-0.04	-0.3	-0.4	-0.12	-0.08	-0.35	0.91	0.91	0.74	-0.36	0.98	0.29		-0.11	-0.48	0.52	0.92	0.54	-0.02	0.91	-0.6	0.16	0.39
Cost Of Revenue	-0.1	0.0	0.16	0.19	0.23	-0.04	0.27	-0.15	-0.18	-0.22	0.24	-0.06	0.31	-0.11		-0.04	0.15	-0.26	-0.66	-0.04	0.15	0.38	-0.91	-0.8
Research Development	0.85	0.43	0.8	0.91	0.82	0.88	0.89	-0.29	-0.31	0.0	0.9	-0.49	-0.6	-0.48	-0.04		-0.32	-0.52	-0.27	0.72	-0.42	0.85	-0.05	-0.35
Income Tax Expense	-0.5	0.05	-0.19	-0.22	-0.04	-0.04	-0.21	0.67	0.68	0.58	-0.22	0.69	0.13	0.52	0.15	-0.32		0.7	0.28	0.09	0.73	-0.33	0.02	0.18
Net Income From Continuing Ops	-0.73	-0.04	-0.37	-0.47	-0.22	-0.13	-0.46	0.91	0.91	0.75	-0.45	0.95	0.22	0.92	-0.26	-0.52	0.7		0.66	0.01	0.87	-0.67	0.35	0.56
Non Operating Income Net Other	-0.2	-0.25	-0.18	-0.28	-0.17	0.01	-0.33	0.63	0.65	0.66	-0.31	0.53	-0.25	0.54	-0.66	-0.27	0.28	0.66		0.18	0.39	-0.63	0.65	0.91
Non Recurring	0.59	0.45	0.73	0.81	0.86	0.91	0.79	0.27	0.23	0.53	0.8	0.01	-0.7	-0.02	-0.04	0.72	0.09	0.01	0.18		0.08	0.59	0.0	-0.06
Tax Provision	-0.72	0.08	-0.24	-0.28	0.02	-0.01	-0.21	0.91	0.91	0.77	-0.22	0.95	0.22	0.91	0.15	-0.42	0.73	0.87	0.39	0.08		-0.43	-0.08	0.16
Reconciled Depreciation	0.77	0.48	0.78	0.88	0.78	0.71	0.89	-0.45	-0.47	-0.21	0.88	-0.59	-0.44	-0.6	0.38	0.85	-0.33	-0.67	-0.63	0.59	-0.43		-0.43	-0.73
Extraordinary Items	0.0	-0.09	-0.14	-0.33	-0.37	-0.03	-0.42	0.19	0.21	0.2	-0.39	0.14	-0.17	0.16	-0.91	-0.05	0.02	0.35	0.65	0.0	-0.08	-0.43		0.82
Net Interest Income	-0.23	-0.39	-0.35	-0.46	-0.44	-0.21	-0.54	0.4	0.42	0.37	-0.51	0.38	-0.06	0.39	-0.8	-0.35	0.18	0.56	0.91	-0.06	0.16	-0.73	0.82

Click cells to compare fundamentals

EHealth Account Relationship Matchups

EHealth income statement Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Interest Expense	46.1M	666K	845K	42.9M	11.0M	11.5M
Total Revenue	506.2M	582.8M	538.2M	405.4M	452.9M	475.5M
Gross Profit	503.5M	578.7M	536.2M	403.7M	431.2M	218.0M
Operating Income	129.6M	53.3M	(74.4M)	(83.1M)	(29.1M)	(27.6M)
Ebit	129.6M	53.3M	(74.4M)	(83.1M)	(29.1M)	(27.6M)
Ebitda	138.6M	66.3M	(4.3M)	(42.4M)	(9.2M)	(8.7M)
Income Before Tax	83.5M	54.0M	(124.9M)	(106.4M)	(30.6M)	(29.1M)
Net Income	66.9M	45.5M	(104.4M)	(88.7M)	(28.2M)	(26.8M)
Cost Of Revenue	2.7M	4.1M	2.0M	1.6M	21.7M	22.8M
Research Development	47.1M	65.2M	83.8M	78.8M	61.0M	37.0M
Income Tax Expense	16.6M	8.5M	(20.5M)	(17.7M)	(2.4M)	(2.3M)
Non Recurring	621K	2.0M	51.2M	19.6M	22.6M	12.9M
Tax Provision	16.6M	8.5M	(20.5M)	(17.7M)	571K	599.6K

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards EHealth in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, EHealth's short interest history, or implied volatility extrapolated from EHealth options trading.

Pair Trading with EHealth

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if EHealth position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in EHealth will appreciate offsetting losses from the drop in the long position's value.

Moving together with EHealth Stock

0.68

FANH

Fanhua Inc

Pair Corr

Moving against EHealth Stock

0.6	DIST	Distoken Acquisition	Pair Corr
0.55	C	Citigroup Financial Report 12th of July 2024	Pair Corr
0.44	BRP	Brp Group Financial Report 14th of May 2024	Pair Corr
0.43	ERIE	Erie Indemnity Earnings Call This Week	Pair Corr

The ability to find closely correlated positions to EHealth could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace EHealth when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back EHealth - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling eHealth to buy it.

The correlation of EHealth is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as EHealth moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if eHealth moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for EHealth can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

When determining whether eHealth offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of EHealth's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Ehealth Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Ehealth Stock:

How To Invest In EHealth

Details

Is EHealth Stock a good investment?

Details

What is EHealth's Net Worth?

Details

Largest Insurance Brokers Companies

View

Largest Financial Services Companies

View

Check out EHealth Valuation and EHealth Correlation analysis.

For more detail on how to invest in EHealth Stock please use our How to Invest in EHealth guide.

You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.

Complementary Tools for EHealth Stock analysis

When running EHealth's price analysis, check to measure EHealth's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy EHealth is operating at the current time. Most of EHealth's value examination focuses on studying past and present price action to predict the probability of EHealth's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move EHealth's price. Additionally, you may evaluate how the addition of EHealth to your portfolios can decrease your overall portfolio volatility.

	Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets
	Commodity Directory Find actively traded commodities issued by global exchanges
	Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments
	Fundamental Analysis View fundamental data based on most recent published financial statements
	AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities

Is EHealth's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of EHealth. If investors know EHealth will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about EHealth listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

2.108

Earnings Share

(2.37)

Revenue Per Share

16.165

Quarterly Revenue Growth

0.262

Return On Assets

(0.02)

The market value of eHealth is measured differently than its book value, which is the value of EHealth that is recorded on the company's balance sheet. Investors also form their own opinion of EHealth's value that differs from its market value or its book value, called intrinsic value, which is EHealth's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because EHealth's market value can be influenced by many factors that don't directly affect EHealth's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between EHealth's value and its price as these two are different measures arrived at by different means. Investors typically determine if EHealth is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, EHealth's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

EHealth Income Statement Research

EHealth income statement Correlations

EHealth Account Relationship Matchups

High Positive Relationship

High Negative Relationship

EHealth income statement Accounts

Pair Trading with EHealth

Moving together with EHealth Stock

Moving against EHealth Stock

Complementary Tools for EHealth Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Operating Expenses	+ 1.0	Other Operating Expenses
Other Operating Expenses	+ 0.99	Selling And Marketing Expenses
Total Operating Expenses	+ 0.99	Selling And Marketing Expenses
Ebit	+ 0.99	Operating Income
Net Income	+ 0.98	Income Before Tax
Other Operating Expenses	+ 0.97	Total Revenue

Extraordinary Items	- 0.91	Cost Of Revenue
Net Interest Income	- 0.8	Cost Of Revenue
Net Income	- 0.76	Depreciation And Amortization
Income Before Tax	- 0.76	Depreciation And Amortization
Net Interest Income	- 0.73	Reconciled Depreciation
Net Income From Continuing Ops	- 0.73	Depreciation And Amortization